Вы находитесь на странице: 1из 4

DAFTAR PUSTAKA

Adams DJ, Head GA, Markus MA, Lovicu FJ, van der Weyden L, Kontgen F,
Arends MJ, Thiru S, Mayorov DN, Morris BJ. 2006. Renin Enhancer Is
Critical For Control Of Renin Gene Expression And Cardiovascular
Function. J Biol Chem 281: 3175361
Brunner, R.H., Pully, Nussberger, J. 1995. Method for measuring the activity Of
angiotensin converting enzyme In biological samples. Am. J.
Hypertension 5: 393-398.
Brown, M. J. 2006. Direct Renin Inhibition-A New Way Of Targeting The Renin
System. J Renin Angiotensin Aldosterone Syst. 7: S7-11
Campbell DJ, Kladis A, Skinner SL, Whitworth JA. 1991. Characterization of
Angiotensin Peptides in Plasma of Anephric Man. J Hypertens. 9: 265
274.
Cagnoni, F., Njwe, C.A.N., Zaninelli, A. et al. 2010. Blocking RAAS at different
levels:an update on the use of the direct renin inhibitors alone and in
combination.Vascular Health and Risk Management2010:6 549-559.
Carey, R. M., Siragy, H. M. 2003. Newly Recognized Components Of The ReninAngiotensin System: Potential Roles In Cardiovascular And Renal
Regulation. Endocr Rev 24: 261-71
Chobanian AV, Bakris GL, et.al 2003. Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure; National
Heart, Lung, and Blood Institute; National High Blood Pressure Education
Program Coordinating. Seventh report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure:
the JNC 7 complete report. Hypertension. Vol.42,hh.1206 1252.
Dorn, G. W., Force, T. 2005. Protein kinase cascades in the regulation of cardiac
hypertrophy. J Clin Invest 115: 527537.
Dzau, V. J. 2001. Theodore Cooper Lecture: Tissue angiotensin and pathobiology
of vascular disease: a unifying hypothesis. Hypertension 37: 1047 1052.
DeMello, WC & Frohlich, ED. 2009. Renin Angiotensin System and
Cardiovascular Disease. New York :Humana Press
Doris PA. 2002. Hypertension Genetics, Single Nucleotide Polymorphisms, and
the Common Disease: Common Variant Hypothesis. Hypertension.;39[pt
2]:323336.
Fuchs

S, Josette Philippe, Stephane Germain, Flavie Mathieu, Xvier


Jeunemaitre, Pierre Corvol, Florence Pinet.2002. Functionality of Two

42

New Polymorphisms in the Human Renin Gene Enhancer Region.


Journal of Hypertension. 20:23918
Friis

UG, Jensen BL, Jorgensen F, Andreasen D, Skott O. 2005.


Electrophysiology Of The Renin-Producing Juxtaglomerular cells. Nephrol
Dial Transplant 20: 128790

Gerdes, N., Sukhova, G. K., Libby, P., Reynolds, R. S., Young, J. L., Schonbeck,
U. 2002. Expression of interleukin (IL)-18 and functional IL-18 receptor on
human vascular endothelial cells, smooth muscle cells, and
macrophages: implications for atherogenesis. J Exp Med 195: 245257.
Guyton AC and Hall JE. 1997. Buku Ajar Fisiologi Kedokteran . Alih Bahasa :
Irawati setiawan, LMA Ken Ariata Tengadi, Alex Santoso. Jakarta : EGC
Hayo Castrop, Klaus Ho Cherl, Armin Kurtz, Frank Schweda, Vladimir Todorov,
2010. Physiology of Kidney Renin. Physiol Rev 90: 60773
Jan Danser and Jaap Deinum. 2005. Renin, Prorenin and the Putative (Pro)renin
Receptor. Hypertension 46:1069-1076
Jorge P.K., Dirk J.D., David B. H. et al. 2000. Angiotensin-Converting Enzyme
Inhibition and Angiotensin II Type 1 Receptor Blockade Prevent Cardiac
Remodeling in Pigs After Myocardial Infarction. Circulation.102:15561563.
Kalra, D., Sivasubramanian, N., Mann, D. L. 2002. Angiotensin II induces tumor
necrosis factor biosynthesis in the adult mammalian heart through a
protein kinase C-dependent pathway. Circulation 105: 21982205.
Konoshita T, Kato N, et.al. 2009. Genetic variant of the Renin-Angiotensin
systemand diabetes influences blood pressure response to Angiotensin
receptor blockers. Diabetes Care. Vol.32, hh.1485-149
Kurtz & Wagner. 1999. Cellular Control of Renin Secretion. The Journal of
Experimental Biology 202 : 219-25
Laragh, JH, Sealey. 1990. Renin profiling for diagnosis, risk assessment, and
treatment of
hypertension .Kidney Int. Vol. 44, hh. 11631175
Lips, D. J., deWindt, L. J., van Kraaij, D. J., Doevendans, P. A. 2003. Molecular
determinants of myocardial hypertrophy and failure: alternative pathways
for beneficial and maladaptive hypertrophy. Eur Heart J 24: 883896.
Libby P, Lee RT. 2000 Matrix matters. Circulation 102: 18741876
Lodish H, Berk A, Zipursky SL, et al. 2000. Molecular Cell Biology. 4th edition.
New York: W. H. Freeman; Section 10.5, Eukaryotic Transcription
Activators and Repressors.

42

Lukitasari, M, Rohman, MS & Hendrawan, D 2011. Achievement of blood


pressure target with angiotensin blockage based therapy in outpatient
clinic. 5th scientific meeting of Indonesian society of hypertension
Lucienne, J., Nussberger, J., Menard, J. 1990. Determinants of Angiotensin II
Generation During Converting Enzyme Inhibition. Hypertension 16:564572
Mancia G, De Backer G, et al. 2007. Guidelines for the management of arterial
hypertension: The Task Force for the Management of Arterial
Hypertension of the European Society of Hypertension (ESH) and of the
European Society of Cardiology (ESC). J Hypertens. Vol. 25, hh.1105
1187
Masuyer, G., Schwager, S.L.U., Sturrock, E.D. 2012. Molecular recognition and
regulation of human angiotensin-I converting enzyme (ACE) activity by
natural inhibitory peptides. Sciencetific Report 2:717.
Mehta, P. K., Griendling, K. K. 2007. Angiotensin II cell signalling: physiological
and pathological effects in the cardiovascular system. Am J Physiol Cell
Physiol 292: C82-C97Mirny, L.A and Gelfand, M.S. 2002. Structural
Analysis of Conserved Base Pairs in Protein-DNA Complexes. Nucleic
Acids Res.30(7) :1704-11
Munshi, M. K., Uddin, M. N., Glaser, S. S. 2011. The Role Of The ReninAngiotensin System In Liver Fibrosis. Exp Biol Med 236: 557-66
Niamh Moore, Patrick Dicker, John K. O'Brien, Milos Stojanovic, Ronan M.
Conroy, Achim Treumann, Eoin T. O'Brien, Desmond Fitzgerald, Denis
Shields and Alice V. Stanton. 2007. Renin Gene Polymorphisms and
Haplotypes, Blood Pressure, and Responses to Renin-Angiotensin
System Inhibition. Hypertension. 2007;50:340-347
Pan L, Glenn ST, Jones CA, Gronostajski RM, Gross KW. 2004. Regulation Of
Renin Enhancer Activity By Nuclear Factor I And Sp1/ Sp3. Biochim
Biophys Acta 1625: 280290
Parsons, K. K., dan Cofman, T. M. 2007. The renin-angiotensin system: its all in
your head. Journal of Clinical Investigation 117: 873-876.
Persson PB, Angela Skalweit, Ralf Mrowka and Bernd-Joachim Thiele. 2003.
Control of Renin Synthesis. Am J Physiol Regul Integr Comp Physiol
285:R491-R497
Pueyo, M. E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J. F., Michel, J. B.
2000. Angiotensin II stimulates endothelial vascular cell adhesion
molecule-1 via nuclear factor-kappaB activation induced by intracellular
oxidative stress. Arterioscler Thromb Vasc Biol 20: 645651.

42

Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., Suzuki, Y., Mezzano, S.,
et al. 2001. Role of the renin-angiotensin system in vascular diseases:
expanding the field. Hypertension 38: 13821387.
Rhoades, RA & Bell, DR. 2009. Medical Physiology : Priciples fro Clinical
Medicine 3rd. Phildephia : Lippicont Williams & Wilkins. Influences Blood
Pressure Response To Angiotensin Receptor Blockers. Diabetes Care.
32:1485-90
Reudelhuber, T. L. 2005. The renin-angiotensin system: peptides and enzymes
beyond angiotensin II. Curr Opin Nephrol Hypertens 14: 155-159
Stanton, A. 2003. Theurapeutic Potential of Renin Inhibitors in the Management
of Cardiovascular Disorders. Am J Cardiovasc Drugs 3: 389-94.
Thomas, G. P., John, E. H., Lawrence, J. A., Bonita, E. F., John, G., Matha, N. H.,
et al. 2005. Recommendations for Blood Pressure Measurement in
Humans and Experimental Animals: Part 1: Blood Pressure Measurement
in Humans: A Statement for Professionals from the Subcommittee of
Professional and Public Education of The American Heart Association
Council on High Blood Pressure Research. Hypertension 45: 142-161
.
Wagner C, Kurtz A. 1998. Regulation of renal renin release. Curr Opin Nephrol
Hypertens 7: 43741
Watkins WS, Hunt SC, Williams GH, et al. 2011. Genotype-phenotype analysis of
angiotensinogen polymorphisms and essential hypertension: the
importance of haplotypes. J Hypertens; 28: 6575.
Watson J, Baker TA, Bell SP, Gann A, Levine M, Losick R .2004. Molecular
Biology of the Gene. Part 2, Chapter 6 : Maintenance of the Genome. San
Fransisco : Pearson Benjamin Cummings
Woodiwiss, A. J., Nkeh, B., Samani, N. J., Badenhorst, D., Maseko, M., Tiago, A.
D., et al. 2006. Functional Variants Of The Angiotensinogen Gene
Determine Antihypertensive Responses To Angiotensin-Converting
Enzyme Inhibitors In Subjects Of African Origin. Journal of Hypertensive
24: 1057-64.
Ying L, Morris BJ, Sigmund CD. 1997. Transactivation Of The Human Renin
Promoter By The Camp/Protein Kinase A Pathway Is Mediated By Both
Camp-Responsive Element Binding Protein-1 (Creb)-Dependent And
Creb-Independent Mechanisms In Calu-6 Cells. J Biol Chem 272: 2412
20

42